Literature DB >> 3754683

Co-release of neuropeptide Y and catecholamines upon adrenal activation in the cat.

J M Lundberg, G Fried, J Pernow, E Theodorsson-Norheim.   

Abstract

The release of neuropeptide Y (NPY)-like immunoreactivity (-LI) in relation to catecholamines from the cat adrenal was studied in anaesthetized animals. Abdominal surgery increased plasma levels of NPY-LI from 65 +/- 6 to 149 +/- 26 pmol l-1. A positive veno-arterial concentration gradient over the adrenal gland was found for both NPY-LI, adrenaline (Adr) and noradrenaline (NA) during basal conditions. Asphyxia for 2 min increased the output of both NPY-LI and catecholamines from the adrenal. Electrical stimulation of the splanchnic nerve caused a marked increase in adrenal output of NPY-LI and catecholamines. The adrenal content of NPY-LI, as well as the release of NPY-LI from the adrenal, was at least 1000-fold lower on a molar basis than that of catecholamines. The concentration of NPY-LI in the adrenal vein upon splanchnic nerve stimulation was in the nM range. Reversed-phase HPLC characterization revealed that NPY-LI in the adrenal, and in the adrenal venous plasma collected during splanchnic nerve stimulation, was closely related to synthetic porcine NPY. Stimulation with bursts of 20 Hz for 1 S with 10 s intervals for 2 min caused a four-fold higher output of NPY-LI and Adr compared to a continuous stimulation with 2 Hz, giving the same number of impulses. The NA output, however, was only slightly increased by burst stimulation. Guanethidine did not reduce the adrenal output of NPY-LI or catecholamines induced by splanchnic nerve stimulation, while the release was abolished by chlorisondamine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3754683     DOI: 10.1111/j.1748-1716.1986.tb07810.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  14 in total

Review 1.  Role of neurotransmitters and neuropeptides in the regulation of the adrenal cortex.

Authors:  C Delarue; V Contesse; S Lenglet; F Sicard; V Perraudin; H Lefebvre; M Kodjo; F Leboulenger; L Yon; N Gallo-Payet; H Vaudry
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

Review 2.  Osteoblastic Actions of the Neuropeptide Y System to Regulate Bone and Energy Homeostasis.

Authors:  Harry Horsnell; Paul A Baldock
Journal:  Curr Osteoporos Rep       Date:  2016-02       Impact factor: 5.096

Review 3.  Receptor-receptor interactions in central cardiovascular regulation. Focus on neuropeptide/alpha(2)-adrenoreceptor interactions in the nucleus tractus solitarius.

Authors:  Z Díaz-Cabiale; C Parrado; K Fuxe; L Agnati; J A Narváez
Journal:  J Neural Transm (Vienna)       Date:  2006-09-21       Impact factor: 3.575

4.  Neuropeptide Y overflow and metabolism in skeletal muscle arterioles.

Authors:  Kirk W Evanson; Audrey J Stone; Allyson L Hammond; Heidi A Kluess
Journal:  J Physiol       Date:  2011-05-09       Impact factor: 5.182

5.  Reserpine-induced depletion of neuropeptide Y from cardiovascular nerves and adrenal gland due to enhanced release.

Authors:  J M Lundberg; A Al-Saffar; A Saria; E Theodorsson-Norheim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

6.  Actions of neuropeptide Y on innervated and denervated rat tail arteries.

Authors:  T O Neild
Journal:  J Physiol       Date:  1987-05       Impact factor: 5.182

7.  Frequency-dependent effects of activation and inhibition of protein kinase C on neurohypophysial release of oxytocin and vasopressin.

Authors:  K Racké; F Burns; B Haas; J Niebauer; E Pitzius
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

8.  Endomorphin-2 is released from newborn rat primary sensory neurons in a frequency- and calcium-dependent manner.

Authors:  Heather L Scanlin; Elizabeth A Carroll; Victoria K Jenkins; Agnieszka Balkowiec
Journal:  Eur J Neurosci       Date:  2008-05-29       Impact factor: 3.386

9.  The role of neuropeptide Y in the ovine fetal cardiovascular response to reduced oxygenation.

Authors:  Emilia M Sanhueza; Anja A Johansen-Bibby; Andrew J W Fletcher; Raquel A Riquelme; Alejandro J Daniels; Maria Serón-Ferré; Cristián R Gaete; Jorge E Carrasco; Aníbal J Llanos; Dino A Giussani
Journal:  J Physiol       Date:  2003-02-01       Impact factor: 5.182

10.  Dependence of non-adrenergic inhibition of cardiac vagal action on peak frequency of sympathetic stimulation in the dog.

Authors:  T D Gardner; E K Potter
Journal:  J Physiol       Date:  1988-11       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.